吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Feb 4 2022

Full Issue

Without Moderna, African Researchers Nearly Copy Its Vaccine

Afrigen Biologics and Vaccines, from Cape Town, has nearly built a copy of Moderna's mRNA covid vaccine after Moderna refused a partnership request. Separate reports say Africa's covid vaccine effort needs an extra $1.29 billion in funding to boost the rollout to more people.

Researchers at a South African biotechnology company say they have nearly created a copy of Moderna鈥檚 messenger-RNA-based vaccine against COVID-19, without Moderna鈥檚 involvement. The company, Afrigen Biologics and Vaccines, in Cape Town, has made only microlitres of the vaccine, based on data that Moderna used to make its shot. But the achievement is a milestone for a major initiative launched by the World Health Organization (WHO) 鈥 a technology transfer hub meant to build capacity for vaccine manufacturing in low- and middle-income countries. (2/3)

South Africa鈥檚 Afrigen Biologics & Vaccines Ltd. said it has made a Covid-19 vaccine that matches the one by Moderna Inc. after that company rebuffed it in its request for a partnership. Afrigen, part of the World Health Organization鈥檚 mRNA technology transfer hub in Cape Town, obtained the publicly available sequence of the Moderna shot from Stanford University and has now made its own version, Petro Terblanche, the managing director of Afrigen, said. (Sguazzin, 2/4)

Africa is short of at least $1.29 billion to fund the rollout of Covid-19 vaccines, the World Health Organization said, citing data from 40 of the continent鈥檚 54 countries. Only 11% of the continent鈥檚 1.2 billion people are fully vaccinated and the weekly pace of vaccination needs to rise sixfold to hit a target of having 70% of the population inoculated by the middle of this year, the WHO said in a statement on Thursday. Currently six million Africans are being vaccinated weekly. (Sguazzin, 2/3)

A sub-variant of the omicron coronavirus strain, known as BA.2, is spreading rapidly in South Africa and may cause a second surge of infections in the current wave, one of the country鈥檚 top scientists said. BA.2 is causing concern as studies show that it appears to be more transmissible than the original omicron strain, the discovery of which was announced by South Africa and Botswana in November.聽Research also shows that getting a mild infection with either of the two strains may not give a robust enough immune response to protect against another omicron infection. There鈥檚 no indication that the sub-variant causes more severe disease from infection surges seen in Denmark and the U.K. (Sguazzin, 2/2)

In other global pandemic news 鈥

The director of the World Health Organization鈥檚 Europe office said Thursday that coronavirus deaths are starting to plateau and the continent faces a 鈥減lausible endgame鈥 to the pandemic. Dr. Hans Kluge said there is a 鈥渟ingular opportunity鈥 for countries across Europe to take control of COVID-19 transmission as a result of three factors: high levels of immunization because of vaccination and natural infection, the virus鈥檚 tendency to spread less in warmer weather and the lower severity of the omicron variant. Data in the U.S. is similar to the data from Europe, providing similar hope. 鈥淭his period of higher protection should be seen as a cease-fire that could bring us enduring peace,鈥 Kluge said. (Bacon, Ortiz and Tebor, 2/3)

It is becoming the mantra of 2022, the most optimistic formulation for the end of the pandemic 鈥 less ambitious than 鈥渟top covid鈥 but more than 鈥渇latten the curve.鈥 The world, we are told, must learn to 鈥渓ive with the virus.鈥 But what 鈥渓ive with the virus鈥 means may depend on where you live. ... Health experts have warned against declaring that moment too soon. But many countries in Europe, where vaccination rates are high and hospitalizations through the omicron wave have been manageable, think they will get there before the United States does. (Noack, Rolfe and Booth, 2/3)

Direct international flights to Bali have resumed for the first time in two years as Indonesia opens the resort island to foreign travelers from all countries, but mandatory quarantine remains in place for all visitors. Officials had said in October that Bali would welcome foreign arrivals from 19 countries that meet World Health Organization criteria, such as having their COVID-19 cases under control. But there were no direct international flights to Bali until Thursday, when Garuda Indonesia operated its first such flight in two years from Tokyo. (Lisnawati, 2/4)

Austria is the first Western democracy to mandate Covid vaccinations for nearly its entire adult population, a once-unthinkable move that is being seen as a test case for other countries grappling with pockets of vaccine resistance. The sweeping measure, which easily cleared its final parliamentary hurdle on Thursday when it was approved by lawmakers in Austria鈥檚 upper house, will be signed into law as soon as Friday by President Alexander Van der Bellen of Austria. (Bennhold, 2/4)

For citizens of a country where aids, dysentery and road traffic accidents rank among the top ten causes of death, it is difficult to get worked up about a newfangled ailment like covid-19. And when friends and family appear more scared of vaccination than of infection itself鈥攚hen they say that a jab is a one-way ticket to hell鈥攊t is perhaps natural to resist getting inoculated. Little surprise then that Papua New Guinea, a desperately poor corner of the world, has the lowest vaccination rate in Asia and among the lowest in the world. Just 3.3% of the population has received even a single dose. (2/4)

Teachers fear children have become 鈥渇eral鈥, suffer 鈥渆xtreme鈥 separation anxiety and struggle to play football with others as a result of the pandemic disrupting their education, ministers have been told. MPs raised concerns shared by teachers in their constituencies as they debated the Government鈥檚 education catch-up and mental health recovery programmes. Time spent learning at home rather than in classroom due to Covid-19 restrictions has disrupted the development of youngsters, the Commons heard. (2/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 4
  • Monday, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF